We are live on ! Find out more
ADIL

Adial Pharmaceuticals
ADIL

7 hedge funds and large institutions have $1.41M invested in Adial Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,409% more capital invested

Capital invested by funds: $56K → $1.41M (+$1.35M)

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

40% more funds holding

Funds holding: 5 → 7 (+2)

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$526K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$99.1K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$35.2K
4
Two Sigma Investments
Two Sigma Investments
New York
+$30.4K
5
UBS Group
UBS Group
Switzerland
+$4.79K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$50K
2
TRCT
Tower Research Capital (TRC)
New York
-$2K
3
Bank of America
Bank of America
North Carolina
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$1.05M +$526K +329 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$200K +$99.1K +62 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$69K +$35.2K +22 New
Two Sigma Investments
4
Two Sigma Investments
New York
$60K +$30.4K +19 New
UBS Group
5
UBS Group
Switzerland
$14K +$4.79K +3 +300%
LTFS
6
Ladenburg Thalmann Financial Services
Florida
$5K +$1.6K +1 New
Morgan Stanley
7
Morgan Stanley
New York
$3K – – –
Wells Fargo
8
Wells Fargo
California
$1K – – –
Millennium Management
9
Millennium Management
New York
– -$50K -27 Closed
Bank of America
10
Bank of America
North Carolina
– -$1K -1 Closed
TRCT
11
Tower Research Capital (TRC)
New York
– -$2K -1 Closed

ADIL Hedge Fund Activity: Q4 2018 in Review

7 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Adial Pharmaceuticals (ADIL) for Q4 2018, worth a combined $1.41M — up 2,409% from $56K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ADIL positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $526K. The largest seller was Millennium Management, exiting entirely with an estimated $50K sold.

  • 7 institutional investors held Adial Pharmaceuticals (ADIL) as of Q4 2018, up from 5 in Q3 2018.
  • Funds reported $1.41M of Adial Pharmaceuticals stock for Q4 2018, up 2,409% quarter-over-quarter.
  • 5 funds opened new Adial Pharmaceuticals positions in Q4 2018 and 3 closed out, a net change of +2 holders.
  • The largest Adial Pharmaceuticals buyer in Q4 2018 was BlackRock, an estimated $526K added.
  • The largest Adial Pharmaceuticals seller in Q4 2018 was Millennium Management, an estimated $50K sold.

Based on aggregated 13F filings for Q4 2018.